Medtronic receives $337m for development of new diabetes technologies
Investment with Blackstone Life Sciences is expected to accelerate Medtronic Diabetes Pump and CGM Technology pipeline. Credit: Tony Webster / Wiki Commons.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more